Symptomtext
administration of Menquadfi today, as per past immunization record patient had his initial dose when he was 12 years old and booster dose when he was 16 years old with no reported adverse event; Initial information on 29-Aug-2023 regarding an unsolicited valid non-serious case received from a Nurse. This case involves a 18 years old male patient who got administration of meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] today, as per past immunization record patient had his initial dose when he was 12 years old and booster dose when he was 16 years old with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included meningococcal vaccine B for Prophylactic vaccination. On 29-Aug-2023, the patient received 0.5 ml (TOTAL) dose 3 of suspect meningococcal a-c-y-w135 (t conj) vaccine Solution for injection (lot U7675CA and expiration date- 01-Oct-2025) via intramuscular route in the right deltoid (strength: not provided) for Immunization (inappropriate schedule of product administration) (latency- same day). Action taken- not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.